Archived research. Equity forecasting is part of the Runchey Research archive (methodology era 1) and is no longer actively updated. Everything remains published at its original URL. Browse the archive
Will Centene achieve adjusted diluted EPS of at least $3.00 for FY2026?
Current Prediction
Prediction Distribution
Individual Predictions(9 runs)
FY2025 delivered $2.08. $3.00 requires 44% improvement. Key drivers: ACA contraction improving HBR, Medicaid rate increases. Management withdrew guidance in 2025 — credibility impaired. Guide beat consensus of $2.50.
Multiple assumptions must hold simultaneously: HBR improvement, ACA contraction, no incremental risk adj losses. Joint probability lower. Management track record poor.
MCOs historically deliver after reset years. The $3.00 may be sandbagged with upside. ACA contraction is the key catalyst.
Pre-guidance consensus $2.50 reflects analyst skepticism. Credibility discount warranted after July 2025 withdrawal.
True coin-flip. Arguments balanced. ACA contraction helps but adverse selection could offset.
All segments must improve simultaneously with 3 different headwinds. Joint probability below 50%.
44% growth needed from impaired management. Near coin-flip.
Clear improvement drivers exist but execution risk high.
Base case slightly below $3.00. Multiple headwinds could offset drivers.
Resolution Criteria
Resolves YES if Centene's FY2026 full-year adjusted diluted EPS (as reported in the FY2026 earnings release, expected February 2027) is $3.00 or above. Resolves NO if below $3.00. Uses Centene's definition of adjusted diluted EPS as reported.
Resolution Source
Centene FY2026 earnings release
Source Trigger
FY2026 adjusted diluted EPS guidance of at least $3.00 — credibility test after FY2025 miss
Full multi-lens equity analysis